Published in Lancet Oncol on March 01, 2015
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. J Clin Oncol (2015) 1.00
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer. J Clin Oncol (2015) 0.85
Collaborative Research in Childhood Cancer Survivorship: The Current Landscape. J Clin Oncol (2015) 0.82
Roadmap for biomarkers of cancer therapy cardiotoxicity. Heart (2015) 0.81
Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. Lancet Diabetes Endocrinol (2015) 0.81
Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol (2016) 0.77
Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT. Bone Marrow Transplant (2016) 0.76
Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer. Biomed Res Int (2016) 0.75
Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant (2016) 0.75
Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup. PLoS One (2016) 0.75
Effect of Population Socioeconomic and Health System Factors on Medical Care of Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study. J Adolesc Young Adult Oncol (2016) 0.75
Factors supporting cardiomyopathy screening among at-risk adult survivors of pediatric malignancies. Support Care Cancer (2016) 0.75
Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study. Med Oncol (2016) 0.75
Lifestyle advice provision to teenage and young adult cancer patients: the perspective of health professionals in the UK. Support Care Cancer (2017) 0.75
Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma. Support Care Cancer (2017) 0.75
Imaging of late complications of cancer therapy in children. Pediatr Radiol (2016) 0.75
Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08
Chronic health conditions in adult survivors of childhood cancer. N Engl J Med (2006) 19.97
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med (1991) 16.19
American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc (2010) 6.18
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med (1995) 5.22
Biomarkers in heart failure. N Engl J Med (2008) 5.20
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet (2001) 4.65
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA (2007) 4.27
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA (2013) 3.65
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med (2004) 3.50
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ (2004) 3.39
Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol (2009) 3.30
Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. J Clin Oncol (2011) 3.05
State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation (2009) 3.05
Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer (2006) 2.99
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol (2005) 2.85
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol (2004) 2.68
Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys (2010) 2.66
Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. J Clin Oncol (2001) 2.62
American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? Circulation (2003) 2.54
Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol (2014) 2.45
Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J (2003) 2.40
Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr (2008) 2.38
Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA (2002) 2.33
Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer (2010) 2.25
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica (2008) 2.20
Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood (2006) 2.18
Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA (1993) 2.17
Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol (2012) 2.07
Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med (2010) 1.87
Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol (2002) 1.87
The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med (2003) 1.84
Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol (2013) 1.83
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation (2004) 1.82
The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr (2012) 1.82
Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol (1992) 1.72
Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML. Pediatr Blood Cancer (2007) 1.69
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol (2011) 1.62
Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol (2009) 1.62
Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev (2010) 1.61
International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant (2004) 1.59
Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood (2012) 1.58
Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom. Pediatr Blood Cancer (2011) 1.55
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol (2012) 1.54
High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol (2012) 1.53
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet (2003) 1.52
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol (2010) 1.52
Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol (2002) 1.50
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. J Clin Oncol (2007) 1.47
Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J Clin Oncol (2009) 1.36
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol (2003) 1.36
Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer (2003) 1.36
Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol (2008) 1.35
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur J Heart Fail (2010) 1.34
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol (2012) 1.32
Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer (2004) 1.29
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol (2004) 1.28
Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med (2014) 1.27
Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects. Ann Intern Med (2014) 1.26
Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. J Clin Oncol (2012) 1.26
Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer (2005) 1.24
Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med (2011) 1.23
Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol (2012) 1.23
Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer (2010) 1.23
Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database Syst Rev (2010) 1.20
Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev (2008) 1.17
Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Hematol Oncol Clin North Am (2010) 1.16
Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. Blood (2011) 1.16
Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421. J Clin Oncol (2008) 1.15
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. J Am Coll Cardiol (1997) 1.14
Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol (2008) 1.12
Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol (2004) 1.11
Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil (2006) 1.11
Exercise interventions in children with cancer: a review. Int J Pediatr (2011) 1.10
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. Circulation (2006) 1.08
Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol (2011) 1.07
Peripartum cardiomyopathy. Crit Care Med (2005) 1.06
Deficits in physical function among young childhood cancer survivors. J Clin Oncol (2013) 1.06
Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. BMJ (2013) 1.02
Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review. Cancer Treat Rev (2005) 1.02
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). J Am Coll Cardiol (2012) 0.99
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant (2007) 0.98
Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol (2014) 1.53
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat Genet (2015) 1.22